References
- 1. Tripodi A. The Long-Awaited Whole-Blood Thrombin Generation Test. Clin Chem. 2012;58(8):1173-5. DOI: 10.1373/clinchem.2012.189266
- 2. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, et al. The Calibrated Automated Thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32:249-53. DOI: 10.1159/000073575
- 3. Marcus D Lance. A general review of major global coagulation assays: thrombelastography, thrombin generation test and clot waveform analysis. Lance Thrombosis J. 2015;13:1. DOI: 10.1186/1477-9560-13-1
- 4. Kern A, Varnai K, Vasarhelyi B. Thrombin generation assays and their clinical application. Orv Hetil. 2014; 155 (22):851-7. DOI: 10.1556/OH.2014.29899
- 5. Young G, Sorensen B, Dargaud Y, Negrier C, Brummel- Ziedins K, Nigel S, et al. Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives. Blood. 2013; 121 (11):1944-50. DOI: 10.1182/ blood-2012-08-378935
- 6. Mancuso ME, Fasulo MR. Thrombin Generation Assay as a Laboratory Monitoring Tool during Bypassing Therapy in Patients with Hemophilia and Inhibitors. Semin Thromb Haemost. 2016;42:30-5.
- 7. Mancuso ME, Chantaragkul V, Clerici M. Low thrombin generation during major orthopedic surgery fails to predict bleeding risk in inhibitor patients treated with bypassing agents. Haemophilia. 2016;22(4):292-30. DOI: 10.1111/hae.12939
- 8. Turecek PL, Varadi K, Keil B, Negrier C, Berntorp E, Astermark J, et al. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol Haemost Thromb. 2003;33 (1):16-22. DOI: 10.1159/000071637
- 9. Dargaud Y, Lienhart A, Meunier S, Hequet O, Chavanne H, Chamouard V, et al. Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision. Haemophilia.2005;11(5):552-8. DOI: 10.1111/j.1365-2516.2005.01141.x
- 10. 1Dargaud Y, Lienhart A, Negrier C. Prospective assessment of thrombin generation test for dose monitoring of bypassing therapy in hemophilia patients with inhibitors undergoing elective surgery. Blood. 2010; 116 (25):5734-7. DOI: 10.1182/blood-2010-06-291906
- 11. Mancuso ME, Chantarangkul V, Clerici M. Thrombin generation assay in hemophilic patients with or without inhibitors undergoing orthopedic surgery. Haemophilia. 2014; 20 (3):10.
- 12. Instrumentation laboratory ACL ELITE* / ELITE PRO System. Reagents, controls and calibrators package’s inserts. PN 722277 Rev. BB (November 2010) Beckman Coulter, Inc.
- 13. Shima M, Matsumoto T, Ogiwara K New assays for monitoring haemophilia treatment. Haemophilia. 2008;3:83-92. DOI: 10.1111/j.1365-2516.2008.01737.x
- 14. Ninivaggi M, Apitz-Castro R, Dargaud Y, de Laat B, Coenraad Hemker H, Lindhout T, et al. Whole- Blood Thrombin Generation Monitored with a Calibrated Automated Thrombogram-Based Assay. Clin Chem. 2012; 58 (8):1252-9. DOI: 10.1373/ clinchem.2012.184077
- 15. Mahlangu J, Kuliczkowski K, Karim FA, Stasyshyn O, Kosinova MV, Lepatan LM, et al. Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A. Blood. 2016; 128 (5): 630-637. DOI: 10.1182/blood-2016-01-687434
- 16. Sorensen B, Ingerslev J. Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Haemophilia. 2005; 11 (1):1-6. DOI: 10.1111/j.1365-2516.2005.01156.x
- 17. Négrier C, Gomperts ED, Oldenburg J. The history of FEIBA: a lifetime of success in the treatment of haemophilia complicated by an inhibitor. Haemophilia. 2006;12:4-13. DOI: 10.1111/j.1365-2516.2006.01379.x
- 18. Dargaud Y, Prevost C, Lienhart A, Bordet JC, Negrier C. Evaluation of the overall haemostatic effect of recombinant factor VIIa by measuring thrombin generation and stability of fibrin clots. Haemophilia. 2011;17:957-61. DOI: 10.1111/j.1365-2516.2011.02526.x
- 19. Vila V, Aznar JA, Moret A, Marco A, Navarro S, Vila C, et al. Assessement of the thrombin generation assay in haemophilia: comparative study between fresh and frozen platelet-rich plasma. Haemophilia. 2013;19:318-21. DOI: 10.1111/hae.12044
- 20. Perrin J, Depasse P, Lecompte T. Large external quality assessment survey on thrombin generation with CAT: further evidence for the usefulness of normalization with an external reference plasma. Thromb Res. 2016;135(1):125-130.